Dynavax to Present at the Jefferies 2012 Global Healthcare Conference
Posted on May 29, 2012 at 16:00 PM EDT

BERKELEY, CA -- (Marketwire) -- 05/29/12 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it plans to present at the Jefferies 2012 Global Healthcare Conference in New York on Tuesday, June 5, at 9:30 a.m. EDT (6:30 a.m. PDT).

Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a corporate overview presentation. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at http://investors.dynavax.com/newsevents.cfm.

About Dynavax

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The Company's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine designed to provide higher and earlier protection with fewer doses than currently licensed vaccines. A U.S. BLA for HEPLISAV has been submitted to the FDA. For more information visit www.dynavax.com.

Contact:
Michael Ostrach
Vice President and Chief Business Officer
510-665-7257
Email Contact

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here